QbD Group published a blog post by experts discussing common pitfalls in European studies related to structural heart and coronary trials, preparation, site selection, imaging consistency, investigator engagement, contracts, budgets, follow-up requirements, and data quality.

QbD Group is your strategic partner in life sciences, supporting companies from early-stage innovation to full market access and lifecycle management. We combine deep regulatory, clinical, and quality expertise to help clients accelerate development, reduce risk, and meet the highest industry standards. Our mission is simple: bring life science innovations to patients faster, safer, and with confidence. With 600+ professionals and a presence across Europe and beyond, we support the full journey - from idea to submission, from validation to market, from start-up to scale-up. Our core solution areas include: - Product Development: Supporting innovators in MedTech and Biotech from idea to patient. - Gateway to Europe: Enabling non-EU companies to access and thrive in the European market. - Operational Excellence: Strengthening manufacturing quality and lifecycle activities. We act as an extension of our clients’ teams - with short decision lines, hands-on delivery, and a passion for solving complex challenges. At QbD Group, we believe that every innovation deserves to reach the patient - and we’re here to make that happen.